MTD (US)


March 5, 2025

Life Science Tools: Court Intervention & NIH’s New Management

By John Leppard

Events today support our view that NIH grant funding benefitting life science tools (LST) manufacturers will likely stabilize, and that the Trump administration’s Feb. 7 announcement of a 15% cap on indirect costs for all…

Read More >>

December 3, 2024

Life Science Tools: NIH Cuts in Context

By John Leppard

With the life science tools (LST) space still trailing broader market moves following the Nov. 5 election, in part due to investor concerns over NIH funding, we continue to believe that significant budget cuts are…

Read More >>